Milestones

Milestones

  • 01 April, 2011

    Anxiset Plus and Anxiset E launched

  • 01 April, 2011

    P-grade amoxycillin incorporated in production of Duciclav-625 tablet for better stability

  • 02 Nov, 2011

    ACTD for Anxiset filed in thailand

  • 02 Jan, 2012

    Nactab (N-Acetylcysteine) for PCOS & Female Infertility launched

  • 01 Nov, 2012

    Muscodol launched

  • 03 Feb, 2013

    To strengthen our base in the market of Anti-inflammatory, Obsurge successfully launched Seradic Plus tablet

  • 06 Feb, 2013

    Obsurge enters Urology segment with Urisurge & Urisurge-D

  • 13 Feb, 2013

    Obsurge enters cardiac and diabetic segment with 11 products

  • 03 June, 2014

    Anxiset now available in Thai market

  • 04 June, 2014

    Anxiset approved by Thai FDA

  • 01 Feb, 2015

    New Dermatology products registered in Thailand

  • 01 Feb, 2015

    New ACTDs filed, 5 more to be filled by year end in Thailand